Inlightened, the tech-enabled insights platform that connects client companies to a vetted network of healthcare professionals, today announced that Rob Ramirez has joined the company as head of strat...

Pharma market research veteran and PBIRG President's Award winner to lead growth strategy for the healthcare insights platform
BOSTON: Inlightened, the tech-enabled insights platform that connects client companies to a vetted network of healthcare professionals, today announced that Rob Ramirez has joined the company as head of strategy. Ramirez brings 30 years of experience in pharmaceutical market research, healthcare insights, and commercial strategy, including senior leadership roles at Pfizer, Ipsos Healthcare, Schlesinger Group (now Trivoca Health), and, most recently, Manifest Health.
Ramirez is a recognized leader in healthcare market research and a recipient of the Pharmaceutical Business Intelligence and Research Group (PBIRG) President's Award for his contributions to pharmaceutical research, as well as a finalist in Constellation Research's SuperNova Awards for his work advancing the use of collaboration technology in qualitative research. Throughout his career, he has helped pharma, biotech, and research agency clients translate complex healthcare data into commercial decisions.
At Inlightened, Ramirez leads the company's growth strategy and will shape how it serves market researchers, pharma insights teams, and research service providers. His focus includes deepening Inlightened's healthcare professional (HCP) and allied health recruitment offering, expanding service lines for clients running qualitative and quantitative healthcare research, and strengthening client experience as the platform scales.
“Inlightened has built something the industry needs: real relationships with vetted healthcare professionals, paired with the technology to recruit them at speed,” said Ramirez. “After three decades on both the pharma and the agency side, I know how hard it is to reach the right physicians, advanced practice providers, and industry professionals for serious research. That's exactly the problem Inlightened solves, and I'm here to help more researchers see what it can do for them.”
“Rob's reputation in pharma market research speaks for itself, and his client-side perspective is invaluable as we keep growing,” added Shelli Pavone, president and co-founder of Inlightened. “He knows our clients and understands what's at stake when business success depends on reaching the right healthcare experts. We're delighted to have him on the team.”
About Inlightened
Inlightened is the go-to SaaS platform for healthcare innovation. It connects client organizations to on-demand insights, via an unparalleled network of curated, vetted, and engaged experts. In addition to being recognized among Forbes’ Inaugural Next 1000, Inlightened has been featured in Crunchbase, Forbes, and MedCity News. Inlightened was acquired by LocumTenens.com, part of the Jackson Healthcare® family of companies, in August of 2023, and operates as an independent entity.
Learn more at www.getinlightened.com.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Nebius Group N.V. (“Nebius Group” or the “Company”; NASDAQ: NBIS), will release its first quarter 2026 financial results on Wednesday, May 13, 2026, before…
NCR Atleos Corporation (NYSE: NATL) (“Atleos”) will release first quarter 2026 financial results after the market close on Wednesday, May 6, 2026. Due…
General Analysis, a company building security infrastructure for agentic AI, today announced $10 million in seed funding led by Altos Ventures, with participation…
Extreme Networks, Inc. (“Extreme”) (Nasdaq: EXTR) today released financial results for its third quarter of fiscal 2026 ended March 31, 2026. “Our fifth…